Manufacturing / Biological Products, Except Diagnostic Substances
CRISPR Therapeutics AG
CRSP
$49.86
-$1.43 (-2.78%)
Price as of Nov 3, 2026 11:59 UTC
4.7 B
Market Cap (Mid Cap)
33%
IV Rank
57.0%
Implied Volatility
Nov 04
Next Earnings
Technical Signals
as of Oct 30
Bearish
0 of 7
Trend
- Above 20-day average $51.93
- Above 50-day average $52.91
- Above 200-day average $53.82 · -4.5%
- Moving averages stacked Not aligned
Momentum
- Golden cross (50/200) Down · 12d ago
- Momentum cross (20/50) Down · 14d ago
Volume
- Below-average volume 0.8x avg
Price & Trend
Daily candles with EMA 20, SMA 50. Drag to zoom.
Options Activity & Greeks
Implied volatility, flow, and dealer positioning from the options market.
Put/Call Ratio
0.17
Bullish skew
Implied Volatility
57.0%
0% percentile
IV vs Realized
Options rich
30d HV 52.4%
Options Heat Map
Delta-risk grid for CRSP options across strikes and expirations. Hover any cell for full Greeks.
Loading option chain data...
Insider Trades
4 buys
35 sells
| Date | Insider | Title | Type | Shares | Value | Since Trade |
|---|---|---|---|---|---|---|
| Oct 26, 2026 | Silver Andrew Jacob | Grant | 9,000 | $0 | +2.0% | |
| Oct 26, 2026 | Silver Andrew Jacob | Grant | 18,000 | $0 | +2.0% | |
| Oct 26, 2026 | KASINGER JAMES R. | Grant | 18,000 | $0 | +2.0% | |
| Oct 26, 2026 | Kulkarni Samarth | Grant | 28,750 | $0 | +2.0% | |
| Oct 26, 2026 | Kulkarni Samarth | Grant | 57,500 | $0 | +2.0% | |
| Oct 26, 2026 | Patel Naimish | Grant | 24,000 | $0 | +2.0% | |
| Oct 26, 2026 | KASINGER JAMES R. | Grant | 9,000 | $0 | +2.0% | |
| Oct 26, 2026 | Patel Naimish | Grant | 12,000 | $0 | +2.0% | |
| Oct 19, 2026 | Kulkarni Samarth | Sell | 47,837 | $2,381,326 | +0.4% | |
| Oct 19, 2026 | Silver Andrew Jacob | Grant | 25,000 | $0 | -0.1% |
Politician Trades in CRSP
| Date | Politician | Party | Type | Amount | Since Buy |
|---|---|---|---|---|---|
| Sep 20, 2021 | Thomas Suozzi | D | Sale | $50K-$100K | — |
| Jun 03, 2021 | Thomas Suozzi | D | Purchase | $50K-$100K | -53.2% |
| Jan 21, 2021 | Marjorie Taylor Greene | R | Purchase | $1K-$15K | -72.2% |
| Jan 05, 2021 | James M Inhofe | Republican | Sale | $1K-$15K | — |
Earnings History
| Date | Quarter | EPS Est. | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| Aug 10, 2026 | Q2 2026 | -$1.23 | |||
| Aug 03, 2026 | Q2 2026 | -$1.23 | |||
| Mar 31, 2026 | Q1 2026 | -$1.25 | -$1.28 | -2.5% | Miss |
| Dec 31, 2025 | Q4 2025 | -$1.18 | -$1.37 | -16.4% | Miss |
| Sep 30, 2025 | Q3 2025 | -$1.29 | -$1.17 | +9.0% | Beat |
| Jun 30, 2025 | Q2 2025 | -$1.45 | -$1.29 | +11.2% | Beat |
| Mar 31, 2025 | Q1 2025 | -$1.28 | -$1.58 | -23.9% | Miss |
Track CRSP with ThetaPal
Get insider trade alerts, AI portfolio analysis, and options roll recommendations for CRSP and your entire portfolio.